RPTR-1-201

N/A

Report date: 2026/02/18 20:02:09

Base Information

Drug NameRPTR-1-201
Drug Alias NameRPTR-1-201
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > TCR therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesRepertoire Immune Medicines
China Registration ClassN/A

Develop Information

Active CompaniesRepertoire Immune Medicines
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A